Antiepileptic drug use in seven electronic health record databases in europe: A methodological comparison

Publication date

2013-10

Authors

De Groot, Mark C. H.ORCID 0000-0002-5764-5788ISNI 0000000010971418
Schuerch, Markus
De Vries, F.ORCID 0000-0003-3837-8319ISNI 0000000393640594
Hesse, Ulrik
Oliva, Belén
Alvarez, Consuelo Huerta
Gil, Miguel
Requena, Gema
Abajo, Francisco
Afonso, Ana

Editors

Advisors

Supervisors

Document Type

Abstract

License

Abstract

Background: The annual prevalence of antiepileptic drug (AED) prescribing reported in the literature differs considerably among European countries; this may be due to differences in type of data sources, time periods, population distributions, and methodology. Objectives: To assess the prevalence of AED prescribing across seven European routine health care databases in Spain, Denmark, the Netherlands, the UK, and Germany using standardised methodology and to investigate sources of variation. Methods: We used data from the Spanish Base de Datos para la Investigación Farmacoepidemiologica en Atencion Primaria (BIFAP), the Danish national registries, the Dutch Mondriaan project (AHC, NPCRD), The Health Improvement Network (THIN) and the Clinical Practice Research Datalink (CPRD) from the UK, and the German Bavarian claims database (KVB). Analyses on annual prevalence of AEDs over the study period of 2001-2009 were stratified by sex, age, and AED type ('old' vs. 'new' depending registration year for marketing). Overall prevalences were standardised to the European 2008 reference population. Results: Prevalence of any AED varied from 79 per 10,000 persons in the Netherlands to 147 per 10,000 persons in Spain in 2001. After standardisation this range decreased to 88 per 10,000 persons in the Netherlands to 144 per 10,000 in Spain and Denmark. In all databases prevalence increased yearly since 2001 with 6% in Denmark to 15% in Spain. This increase could be entirely attributed to an increase in prescribing of 'new' AEDs. AED use increased with age for both females and males up to ages of 80-89 years-old and tended to be somewhat higher in females between 40 and 70 years-old. We did not find differences across databases in the number of AEDs concomitantly used. Conclusions: During the study period of 2001-2009, AED prescribing increased in all five EU countries which was mainly due to newer AEDs. Using a standardised methodology showed consistent trends across databases and countries over time. Differences in age and sex distribution explained part of the variation between countries.

Keywords

anticonvulsive agent, drug use, electronic medical record, data base, Europe, pharmacoepidemiology, risk management, prevalence, Spain, Denmark, Netherlands, human, methodology, female, United Kingdom, population distribution, population, registration, health, register, clinical practice, Germany, marketing, male, sex ratio, health care, prescription, SDG 3 - Good Health and Well-being

Citation

De Groot, M C H, Schuerch, M, De Vries, F, Hesse, U, Oliva, B, Alvarez, C H, Gil, M, Requena, G, Abajo, F, Afonso, A, Souverein, P C, Alvarez, Y, Slattery, J, Rottenkolber, M, Schmiedl, S, Van Dijk, L, Schlienger, R G, Reynolds, R & Klungel, O 2013, 'Antiepileptic drug use in seven electronic health record databases in europe: A methodological comparison', Pharmacoepidemiology and Drug Safety, vol. 22, no. s1, 585, pp. 289-290. https://doi.org/10.1002/pds.3512